Allergan Inc. (AGN) reported that its third-quarter net earnings attributable to stockholder were $179.0 million or $0.58 per share, compared to $165.4 million or $0.54 per share in the year ago quarter.
Non-GAAP earnings share attributable to stockholders were $215.4 million or $0.70, compared to $200.4 million or $0.65 per share in the third quarter of 2008. Analysts polled by Thomson Reuters expected the company to report earnings of $0.70 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $1.14 billion, compared to $1.10 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $1.08 billion for the quarter.
Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on November 30, 2009 to stockholders of record on November 9, 2009.
For comments and feedback: editorial@rttnews.com